Showing 161 - 180 results of 1,135 for search '"clinical study"', query time: 0.12s Refine Results
  1. 161

    Efficacy of Intrathecal 0.75% Hyperbaric Ropivacaine versus 0.5% Hyperbaric Bupivacaine for Elective Inguinal and Perineal Surgery: A Randomised Double-blinded Clinical Study by Bhavini Shah, Dipanjali Mahanta

    Published 2025-02-01
    “…Materials and Methods: The present randomised double-blind clinical study, was carried out in the Department of Anaesthesia, Dr. …”
    Get full text
    Article
  2. 162
  3. 163
  4. 164
  5. 165
  6. 166
  7. 167

    Comparative Evaluation of Clinical and Radiographic Changes Following Delayed Implant Placement in Mandibular Posterior Region with or without i-PRF Activation: A Split Mouth Clinical Study by Shivam Singh, Yasir S. Khan, Amitabh Srivastava, Vivek Srivastava, Ajita Meenawat, Tanu Sahney

    Published 2024-12-01
    “…Methods: A split-mouth clinical study design was used, involving ten participants with twenty sites of bilaterally missing mandibular molars. …”
    Get full text
    Article
  8. 168
  9. 169
  10. 170
  11. 171
  12. 172

    Accuracy of ESAT6-CFP10 skin test compared with tuberculin skin test in a healthy population: a randomized, blind, parallel controlled phase III clinical study by Xiaoyan Ding, Weixin Du, Qiao Liu, Lifeng Tao, Yan Shao, Peng Lu, Huaiyu Yang, Xiaoxue Teng, Cheng Chen, Zhongqi Li, Jinbiao Lu, Aihua Zhao, Guozhi Wang, Miao Xu, Limei Zhu

    Published 2024-12-01
    “…Clinical trials Registration NCT02795260, Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18–65(III-healthy), Registration Date: June 10, 2016.…”
    Get full text
    Article
  13. 173
  14. 174
  15. 175
  16. 176
  17. 177
  18. 178
  19. 179

    AOZORA: long-term safety and joint health in paediatric persons with haemophilia A without factor VIII inhibitors receiving emicizumab – protocol for a multicentre, open-label, phase IV clinical study by Seitaro Yoshida, Masashi Taki, Hideyuki Takedani, Midori Shima, Keiji Nogami, Azusa Nagao, Haruko Yamaguchi-Suita, Yui Kyogoku, Akira Ishiguro, Kaoru Kitsukawa

    Published 2022-06-01
    “…The AOZORA study will evaluate the long-term safety and joint health of paediatric PwHA without factor (F)VIII inhibitors taking emicizumab; here, we report the details of the study protocol and baseline data.Methods and analysis AOZORA is a multicentre, open-label, phase IV clinical study in Japan that aims to enrol approximately 30 PwHA aged <12 years without FVIII inhibitors. …”
    Get full text
    Article
  20. 180